Redwood Scientific Technologies, Inc. (RSCI)

OTCMKTS · Delayed Price · Currency is USD
0.1000
-0.0100 (-9.09%)
May 8, 2025, 4:00 PM EDT
-83.87%
Market Cap 35.85M
Revenue (ttm) 259.71K
Net Income (ttm) -979.33K
Shares Out 204.94M
EPS (ttm) -12.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,000
Average Volume 1,869
Open 0.1100
Previous Close 0.1100
Day's Range 0.1000 - 0.1100
52-Week Range 0.0600 - 1.2300
Beta 6.84
RSI 60.43
Earnings Date n/a

About RSCI

Redwood Scientific Technologies, Inc. develops and markets over-the-counter FDA registered drugs through oral strip delivery technology. The company is based in Claremont, California. [Read more]

Sector Healthcare
CEO Benjamin Lefrancois
Employees 5
Stock Exchange OTCMKTS
Ticker Symbol RSCI
Full Company Profile

Financial Performance

In 2011, RSCI's revenue was $265,771, an increase of 19.68% compared to the previous year's $222,073. Losses were -$960,551, 12.1% more than in 2010.

Financial Statements

News

Redwood Scientific Technologies Inc. Announces Finalization of TBX VAPE FREE Product Flavors

NEW YORK , May 23, 2024 /PRNewswire/ -- Redwood Scientific Technologies Inc. (OTC: RSCI) is excited to announce the finalization of the first five flavors of its innovative TBX VAPE FREE strips. This ...

1 year ago - PRNewsWire

Redwood Scientific Technologies Inc. (OTC: RSCI) ("Redwood" or "the Company"), a pharmaceutical company, today announced a strategic shift in its product development priorities

NEW YORK , April 18, 2024 /PRNewswire/ -- Redwood Scientific Technologies Inc. (OTC: RSCI) ("Redwood" or "the Company"), a pharmaceutical company, today announced a strategic shift in its product deve...

1 year ago - PRNewsWire

Company Initiates Plans to Build Oral Thin Film Manufacturing in the USA for Its Stop Smoking and Stop Vaping Products

NEW YORK , March 14, 2024 /PRNewswire/ -- Redwood Scientific Technologies Inc. (OTC: RSCI) is excited to announce significant milestones achieved in the year ending 2023 and its strategic plans moving...

1 year ago - PRNewsWire

Redwood Scientific Enters into Agreement with Jeeva Clinical Trials to Launch Clinical Effectiveness Study of its TBX-Free Oral Strips for Smoking and E-cigarette Cessation

Company Has Engaged George Mason University to Conduct Efficacy Study on its New Product NEW YORK , Feb. 6, 2024 /PRNewswire/ -- Redwood Scientific Technologies Inc. (OTC: RSCI), ("Redwood" or "the Co...

1 year ago - PRNewsWire

Redwood Scientific Technologies Inc. (RSCI.OTC.PK) Announces Successful S1 Registration Filing and Provides Updates on TBX FREE Clinical Trial Progress

NEW YORK , Sept. 18, 2023 /PRNewswire/ -- Redwood Scientific Technologies is delighted to announce the successful filing of its S1 registration statement with the Securities and Exchange Commission (S...

1 year ago - PRNewsWire

Redwood Scientific Technologies Inc. (RSCI. OTC. PK) Issues Correction Regarding Agreement with Silk Road Ent.

NEW YORK , Aug. 15, 2023 /PRNewswire/ -- Redwood Scientific Technologies Inc. wishes to correct a previous press release issued on July 19th.

1 year ago - PRNewsWire